Understanding chlorhexidine decolonization strategies

Intensive Care Medicine

Volumn 41, Issue 7, 2015, Pages 1351-1354

  Noto, Michael J ^a   Wheeler, Arthur P ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CATHETER INFECTION; CONTAMINATION; CRITICALLY ILL PATIENT; EMERGENCY CARE; HAND WASHING; HEALTH CARE COST; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; VENTILATED PATIENT; BACTERIAL COUNT; CRITICAL ILLNESS; CROSS INFECTION; DRUG EFFECTS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; CRITICAL ILLNESS; CROSS INFECTION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84933279064     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3846-6     Document Type: Article

References (17)

1. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM (2007) Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 122:160–166
2. Roberts RR, Scott RD 2nd, Hota B, Kampe LM, Abbasi F, Schabowski S, Ahmad I, Ciavarella GG, Cordell R, Solomon SL, Hagtvedt R, Weinstein RA (2010) Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 48:1026–1035
3. Rello J, Koulenti D, Blot S, Sierra R, Diaz E, De Waele JJ, Macor A, Agbaht K, Rodriguez A (2007) Oral care practices in intensive care units: a survey of 59 European ICUs. Intensive Care Med 33:1066–1070
4. Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM (2014) Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 174:751–761
5. Seguin P, Laviolle B, Dahyot-Fizelier C, Dumont R, Veber B, Gergaud S, Asehnoune K, Mimoz O, Donnio PY, Bellissant E, Malledant Y (2014) Effect of oropharyngeal povidone-iodine preventive oral care on ventilator-associated pneumonia in severely brain-injured or cerebral hemorrhage patients: a multicenter, randomized controlled trial. Crit Care Med 42:1–8
6. Popovich KJ, Lyles R, Hayes R, Hota B, Trick W, Weinstein RA, Hayden MK (2012) Relationship between chlorhexidine gluconate skin concentration and microbial density on the skin of critically ill patients bathed daily with chlorhexidine gluconate. Infect Control Hosp Epidemiol 33:889–896
7. Karki S, Cheng AC (2012) Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect 82:71–84
8. Derde LP, Dautzenberg MJ, Bonten MJ (2012) Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med 38:931–939
9. Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368:533–542
10. Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM (2013) Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 381:1099–1106
11. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255–2265
12. Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, Wheeler AP (2015) Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 313:369–378
13. Calogiuri GFDLE, Trautmann A, Nettis E, Ferrannini Vacca A, Vacca A (2013) Chlorhexidine hypersensitivity: a critical and updated review. J Allergy Ther 4:141
14. Xue Y, Zhang S, Yang Y, Lu M, Wang Y, Zhang T, Tang M, Takeshita H (2011) Acute pulmonary toxic effects of chlorhexidine (CHX) following an intratracheal instillation in rats. Hum Exp Toxicol 30:1795–1803
15. Suwantarat N, Carroll KC, Tekle T, Ross T, Maragakis LL, Cosgrove SE, Milstone AM (2014) High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections. Infect Control Hosp Epidemiol 35:1183–1186
16. Wang JT, Sheng WH, Wang JL, Chen D, Chen ML, Chen YC, Chang SC (2008) Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Antimicrob Chemother 62:514–517
17. Derde LP, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJ, Gniadkowski M, Hryniewicz W, Empel J, Dautzenberg MJ, Annane D, Aragao I, Chalfine A, Dumpis U, Esteves F, Giamarellou H, Muzlovic I, Nardi G, Petrikkos GL, Tomic V, Marti AT, Stammet P, Brun-Buisson C, Bonten MJ (2014) Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14:31–39